ArriVent BioPharma, Inc. (AVBP)
NASDAQ·Healthcare·Biotechnology
$31.05
+4.76%
Mkt Cap $1.43B
Analyst Ratings
Buy
7
Hold
0
Sell
0
Price Target (8 analysts)
$45.00
Range $45.00 – $45.00
Implied Upside
+44.9%
Consensus $45.00 vs current $31.05
NASDAQ·Healthcare·Biotechnology
$31.05
+4.76%
Mkt Cap $1.43B
Buy
7
Hold
0
Sell
0
Price Target (8 analysts)
$45.00
Range $45.00 – $45.00
+44.9%
Consensus $45.00 vs current $31.05